IDAS Reports

Virginia Tobacco Settlement Foundation

Drug Policy Series, No. 1 [pdf

Publications for 2004 - 2005 | Publications for 2003 - 2004 | Publications for 2002 - 2003

IDAS Faculty Publications for July 2004 to June 2005

Aceto, M.D., Bowman, E.R., Harris, L.S. and May, E.L. (2004). Dependence studies of new compounds in the rhesus monkey, mouse and rat. Proceedings of the College on Problems of Drug Dependence. NIDA Research Monograph. 184:170-204.

Aceto, M.D., Bowman, E.R., Harris, L.S. and May, E.L. (2005). Dependence studies of new compounds in the rhesus monkey, mouse and rat. Proceedings of College on Problems of Drug Dependence, NIDA Research Monograph. 184:160-200.

Acosta, M.C., Buchhalter, A.R., Breland, A.B., Hamilton, D.C.P., Eissenberg, T. (2004). Urine cotinine as an index of smoking status in abstinent smokers: Comparison of GC/MS with Immunoassay Test Strip. Nicotine and Tobacco Research. 6:615-620.

Adams, E.H., Dart, R.C., Knisely, J.S. and Schnoll, S.H. (2005). Tramadol abuse and dependence among physicians. Journal of American Medical Association. 293(16):1977.

Alekseeva, O.O., Mahadevan, A., Wiley, J.L., Martin, B.R. and Razdan, R.K. (2005). Synthesis of novel 5-substituted pyrazole  derivatives as cannabinoid antagonists. Tetrahedron Letters. 46:2159-2161.

Alemi, F., Taxman, F.S., Dyson, V., Thanner, M. and Baghi, H. (2004). “Activity Based Costing of Probation with and without Substance Abuse Treatment,” The Journal of Mental Health Policy and Economics. 7:51-57.

Asfar, T., Ward, K.D., Eissenberg, T., Maziak, W. (2005). Comparison of patterns of use, beliefs, and attitudes related to waterpipe between beginning and established smokers. BioMed Central Public Health. 5:19.

Ashcraft, A.M. and Belgrave, F.Z. (2004). Gender Identity development in African American girls. Chapter in The Psychology of Gender Identity, Nova Science Publishers.

Balster, R.L. (2005). In: Pharmacology of Inhalants. Zvartau, E.E. (Ed.) Inhalants. St. Petersburg: Pavlov Medical University Publishing House, pp. 25-44.

Balster, R.L. (2005). Drug and Alcohol Dependence adopts new editorial structure. Editorial in Drug and Alcohol Dependence. 78:233-234.

Balster, R.L., Ian Stolerman service as editor. (2005). Editorial in Drug and Alcohol Dependence. 78:111-112.

Barker, S.B., Knisely, J.S., McCain, N.L. and Best, A.M. (2005). Measuring stress and immune response in healthcare professionals following interaction with a therapy dog: A pilot study. Psychological Reports. 96:713-729.

Bass, C.E., Welch, S.P., Martin, B.R. (2004). Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors. European Journal of Pharmacology. 496(1-3):99-108.           

Batman, A.M., Munzar, P. and Beardsley, P.M. (2005). Attenuation of nicotine’s discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Psychopharmacology. 179:393-401.

Beardsley, P.M., Aceto, M.S., Cook, C.D., Bowman, E.R., Newman, J.L. and Harris, L.S. (2004). Discriminative Stimulus, Reinforcing, Physical dependence and antinociceptive effects of oxycodone in mice, rats and rhesus monkeys. Experimental and Clinical Psychopharmacology. 3:163-172.

Belgrave, F.Z., Reed, M.C., Plybon, L.E., Corneille, M. (2004). The impact of a culturally enhanced drug prevention program on drug and alcohol refusal efficacy among urban African-American girls. Journal Drug Education. 34:267-279.

Belgrave, F.Z., Reed, M.C., Plybon, L.E., Butler, D.S., Allison, K.W. and Davis, T. (2004). Sisters of Nia: A cultural program for African-American girls. Journal of Black Psychology. 30:329-343.

Bespalov, A.Y. and Balster, R.L. (2005). Glutamatergic mechanisms of drug relapse: Withdrawal and conditioning factors. In: Schmidt, W.J. and Reith, M.E.A. (Eds.) Dopamine and Glutamate in Psychiatric Disorders. Totowa, NJ: Humana Press, pp. 387-412.

Bouffard, J.A. and Taxman, F.S. (2004). “Looking Inside the ‘Black Box’ of Drug Court Treatment Services Using Direct Observations,” Journal of Drug Issues. 34(1):195-218.

Britt, G.C., McCance-Katz, E.F. (2005). A brief overview of the clinical pharmacology of “club drugs.” Substance Use and Misuse. 40(9-10):1189-201.

Buchhalter, A.R., Acosta, M.C., Evans, S.E., Breland, A.B., Eissenberg, T. (2005). Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction. 100:550-559.

Byrne, J.M. and Taxman, F.S. (2004). “Targeting for Reentry: Inclusion/Exclusion Criteria Across Eight RPI Programs.” Federal Probation, September, 53-61.

Carroll, N.V., Slattum, P.W., Cox, F.M. (2005). The cost of falls among the community-dwelling elderly. Journal of Managed Care Pharmacy. 11(4):307-16.

Carroll, F.I., Ware, R., Brieaddy, L.E., Navarro, H.A., Damaj, M.I., Martin, B.R. (2004). Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2‘-fluoro-3’-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist. Journal of Medicinal Chemistry. 47(18): 4588-4594.

Carroll, F.I., Ma, W., Yokota, Y., Lee, J.R., Brieaddy, L.E., Navarro, H.A., Damaj, M.I., Martin, B.R. (2005). Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3’-substituted deschloroepibatidine analogues. Novel nicotinic antagonists. Journal of Medicinal Chemistry. 48(4):1221-1228.

Cichewicz, D.L., Cox, M.L., Welch, S.P., Selley, D.E. and Sim-Selley, L.J. (2004). Mu and delta opioid-Stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats. European Journal of Pharmacology. 504:33-38.

Cook, C.D., Newman, J.L., Winfree, J.C. and Beardsley, P.M. (2004). Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Pharmacology, Biochemistry and Behavior. 77:309-318.

Cook, C.D., Nickerson, M.D. (2005). Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund’s adjuvant-induced arthritic male and female rats. Journal of Pharmacology and Experimental Therapeutics. 313(1):449-59. Epub 2004 Dec 17.

Cravatt, B.F., Lichtman, A.H. (2004). The endogenous cannabinoid system and its role in nociceptive behavior. Journal of Neurobiology. 61(1):149-60.

Cropsey, K.L. and Kristeller, J.L. (2005). The effects of a prison smoking ban on smoking behavior and withdrawal symptoms. Addictive Behaviors. 30:589-594.

Dalton, G.D., Smith, F.L., Smith, P.A., Dewey, W.L. (2005). Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI). Neuropharmacology. 48(5):648-57.

Dalton, G.D., Smith, F.L., Smith, P.A., Dewey, W.L. (2005). Chronic delta-9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering Protein Kinase A activity in mouse brain and spinal cord. Biochemical Pharmacology. 70:152-160.

Damaj, M.I., Hunter, R.G., Martin, B.R., Kuhar, M.J. (2004). Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice. Brain Research. 1024:146-149.

Damaj, M.I., Carroll, F.I., Eaton, J.B., Navarro, H.A., Blough, B.E., Mirza, S., Lukas, R.J., Martin, B.R. (2004). Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function
of monoamine transporters and nicotinic receptors. Molecular Pharmacology. 66(3):675-682.

Damaj, M.I., Flood, P., Ho, K.K., May, E.L., Martin, B.R. (2005). Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. Journal
of Pharmacology and Experimental Therapeutics. 312(2):780-785. Epub 2004 Sep 8.

Dewey, W.L (2005) Problems of Drug Dependence 2004: Proceedings of the 66th Annual Scientific Meeting. NIDA Research Monograph. Vol. 185.

Fritzinger, A.E., Marciano-Cabral, F. (2004). Modulation of a “CD59-like” protein in Naegleria fowleri amebae by bacteria. Journal of Eukaryotic Microbiology. 51(5):522-528.

Glennon, R.A., Bondarev, M.L., Khorana, N., Young, R., May, J.A., Hellberg, M.R., McLaughlin, M.A., Sharif, N.A. (2004). Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist
1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 47:6034-6041.

Grabus, S.D., Martin, B.R., Batman, A.M., Tyndale, R.F., Sellers, E., Damaj, M.I. (2004). Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology. 178(2-3):183-192.

Grabus, S.D., Martin, B.R., Damaj, M.I. (2005). Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype. European Journal of Pharmacology. 515(1-3):90-93.

Greene, H.A., Horn, J.P., Slattum, P.W. (2005). Management of advanced Parkinson’s disease with concomitant depression: A case study. Consult Pharmacy. 20:432-5.

Haug, N.A., Svikis, D.S., DiClemente, C. (2004). Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychology of Addictive Behaviors. 18(3):289-292.

Herbeck, D.M., Fitek, D.J., Svikis, D.S., Montoya, I.D., Marcus, S.C., West, J.C. (2005). Treatment compliance in patients with comorbid psychiatric and substance use disorders. American Journal of Addictions. 14(3):195-207.

Huffman, J.W., Zengin, G., Wu, M.J., Lu, J., Hynd, G., Bushell, K., Thompson, A.L.S., Bushell, S., Tartal, C., Hurst, D.P., Reggio, P.H., Selley, D.E., Cassidy, M.P., Wiley, J.L. and Martin, B.R. (2005). Structure–activity relationships for 1-alkyl-3-(1-aphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorganic and Medicinal Chemistry. 13:89-112.

Jones, H.E., Svikis, D., Rosado, J., Tuten, M., Kulstad, J.L. (2004). What if they do not want treatment?: lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women. American Journal of Addictions. 13(4):342-357.

Kerns, R.T., Ravindranathan, A., Hassan, S., Cage, M.P., York, T., Sikela, J.M., Williams, R.W., Miles, M.F. (2005). Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. Journal of Neuroscience. 25(9):2255-2266.

Kolanos, R., Siripurapu, U., Pullagurla, M., Riaz, M., Setola, V., Roth, B.L., Dukat, M., Glennon R.A. (2005). Binding of isotryptamines and indenes at h5-HT6 serotonin receptors. Bioorganic Medicinal Chemistry Letters. 15(8):1987-1991.           

Kolhatkar, R., Cook, C.D., Ghorai, S.K., Deschamps, J., Beardsley, P.M., Reith, M.E., Dutta, A.K. (2004). Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: Discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters. Journal of Medicinal Chemistry. 47(21):5101-5113.

Kornstein, S.G., Harvey, A.T., Rush, A.J., Wisniewski, S.R., Trivedi, M.H., Svikis, D.S., McKenzie, N.D., Bryan, C., Harley, R. (2005). Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychological Medicine. 35(5):683-692.

Lee, M., Rangisetty, J.B., Pullagurla, M.R., Dukat, M., Setola, V., Roth, B.L., Glennon, R.A. (2005). 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Bioorganic Medicinal Chemistry Letters. 15(6):1707-1711.

Lichtman, A.H., Leung, D., Shelton, C.C., Saghatelian, A., Hardouin, C., Boger, D.L., Cravatt, B.F. (2004). Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. Journal of Pharmacology and Experimental Therapeutics. 311(2):441-448. Epub 2004 Jun 30.

Lichtman, A.H. and Cravatt, B.F. (2005). Food for thought: endocannabinoid modulation of lipogenesis. Journal of Clinical Investigation. 115(5):1130-1133.

Marciano-Cabral, F. (2004). Introductory remarks: bacterial endosymbionts or pathogens of free-living amebae1. Journal of Eukaryotic Microbiology. 51(5):497-501.

Martin, B.R., Wiley, J.L. (2004). Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain. Journal of Support Oncology. 2(4):305-14; discussion 314-6.

Maziak, W., Eissenberg, T., Rastam, S., Hammal, F., Asfar, T., Bachir, M.E., Fouad, M.F., Ward, K.D. (2004). Beliefs and attitudes related to narghile (waterpipe) smoking among university students in Syria. Annals of Epidemiology. 14:646-654.

Maziak, W., Ward, K.D., Afifi Soweid, R.A., Eissenberg, T. (2004). Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tobacco Control. 13:327-333.

Maziak, W., Ward, K.D., Rastam, S., Mzayek F., Eissenberg, T. (2005). Extent of exposure to environmental tobacco smoke (ETS) and its dose-response relation to respiratory health among adults. Respiratory Research. 6:13.

Maziak, W., Eissenberg, T., Ward, K.D. (2005). Waterpipe use and dependence: implications for intervention development. Pharmacology, Biochemistry and Behavior. 80:173-179.

Maziak, W., Ward, K.D., Afifi Soweid, R.A., Eissenberg, T. (2005). Standardizing questionnaire items for the assessment of waterpipe use in epidemiological studies. BMC Public Health. 119:400-404.

McBride, W.J., Kerns, R.T., Rodd, Z.A., Strother, W.N., Edenberg, H.J., Hashimoto, J.G., Wiren, K.M., Miles, M.F. (2005). Alcohol effects on central nervous system gene expression in genetic animal models. Alcohol Clinical and Experimental Research. 29(2):167-175.
 
McCance-Katz, E.F. (2004). Office-based buprenorphine treatment for opioid-dependent patients. Harvard Review of Psychiatry. 2(6):321-338.

McCance-Katz, E.F., Hart. C.L., Boyarsky, B., Kosten, T., Jatlow, P. (2005). Gender effects following repeated administration of cocaine and alcohol in humans. Substance Use and Misuse. 40(4):511-528.

Nich, C., McCance-Katz, E.F., Petrakis, I.L., Cubells, J.F., Rounsaville, B.J., Carroll, K.M. (2004). Sex differences in cocaine-dependent individuals’ response to disulfiram treatment. Addictive Behaviors. 29(6):1123-1128.

Obando, C.P., Kliewer, W., Murrelle, L. and Svikis, D.S. (2004). The comorbidity of substance abuse and depressive symptoms in Costa Rican adolescents. Drug and Alcohol Dependence. 76:37-44.

Ondersma, S.J., Chase, S.K., Svikis, D.S., Schuster, C.R. (2005). Computer-based brief motivational intervention for perinatal drug use. Substance Abuse Treatment. 28(4):305-312.
 
Perry, B.L., Miles, D.R., Burruss, K. and Svikis, D.S. (2004). Premenstrual symptomatology and alcohol consumption in college women. Journal of Studies on Alcohol. 65(4):464-468.

Philibin, S.D., Vann, R.E., Varvel, S.A., Covington, H.E. III, Rosecrans, J.R., James, J.R., Robinson, S.E. (2005). Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacology, Biochemistry and Behavior. 80:87-92.

Pullagurla, M.R., Westkaemper, R.B., Glennon, R.A. (2005). Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors. Bioorganic Medicinal Chemistry Letters. 14(17):4569-4573.
 
Ramunno, A., Dukat, M., Lee, M., Young, R., El-Zahabi, M., Damaj, M.I., Martin, B., Glennon, R.A. (2005). 6-(2-Phenylethyl) nicotine: A novel nicotinic cholinergic receptor ligand. Bioorganic Medicinal Chemistry Letters. 15:3237-3240.

Rice, R. and Hancock, L. (2005). “The Mall Intercept: A Social Norms Marketing Research Tool.” The Report on Social Norms. Vol 4, No. 7:4-7, Garfiled, NJ, Paper-Clip Communications.

Robinson, S.E., James, J.R., Lapp, L.N., Vann, R.E., Gross, D.E., Philibin, S.D., Rosecrans, J.A. (2005 online). Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance. Psychopharmacology. E-print 1-8.

Scian, M.J., Stagliano, K.E., Ellis, M.A., Hassan, S., Bowman, M., Miles, M.F., Deb, S.P., Deb. S. (2004). Modulation of gene expression by tumor-derived p53 mutants. Cancer Research. 64(20):7447-54.

Setola, V., Dukat, M., Glennon, R.A., Roth, B.L. (2005). Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor. Molecular Pharmacology. 68(1):20-33. Epub 2005 Apr 14.

Shelton, K.L. (2005). Substitution profiles of N-methyl-D-aspartate antagonists in ethanol-discriminating inbred mice. Alcohol. 34(2-3):165-175.

Shelton, K.L. and Balster, R.L. (2004). Effect of abused inhalants and GABA positive modulators in dizocilpine discriminating inbred mice. Pharmacology, Biochemistry and Behavior. 79:219-228.

Shelton, K.L., Dukat, M., Allan, A.M. (2004). Effect of 5-HT3 receptor over-expression on the discriminative stimulus effects of ethanol. Alcohol Clinical and Experimental Research. 28(8):1161-1171.
 
Shelton, K.L., Hendrick, E. and Beardsley, P.M. (2004). Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement. European Journal of Pharmacology. 497(1):35-40.

Sheng, W.S., Hu, S., Min, X., Cabral, G.A., Lokensgard, J.R., Peterson, P.K. (2005). Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-
stimulated human astrocytes. Glia. 49(2):211-219.

Sim-Selley, L.J. (2005). Regional Differences in Adaptation of CNS Mu Opioid Receptors to Chronic Opioid Agonist Administration. Current Neuropharmacology. 3:157-182.

Snavely, K., Taxman, F. and Gordon, S. (2005). “Offender-Based Systems: Transcending Organizational Lines to Promote Proactive Case Management,” in A. Pattavina (ed.) New Advances in Technology for the Criminal Justice System. Sage Publications.
 
Spetea, M., Greiner E., Aceto, M.D., Harris, L.S., Coop, A. and Schmidhammer, H. (2005). Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency. Journal of Medicinal Chemistry. 48:5052-5055.

Stoller, D.C., Smith, F.L. (2005). Buprenorphine blocks withdrawal in morphine-dependent rat pups. Pediatric Anesthesia. 14(8):642-649.

Taxman, F.S. (2004). “The Offender and Reentry: Supporting Active Participation in Reintegration,” Federal Probation, September: 31-35.

Taxman, F.S. and Thanner, M. (2004). “Probation from a Therapeutic Perspective: Results from the Field,” Contemporary Issues in Law, 7(1):39-63.

Taxman, F. (2004). “Of Research and Relevance: Next Steps,” Criminology and Public Policy. 3(2):169-180.

Taxman, F., Young, D. and Byrne, J. (2004). “Transforming Offender Reentry into Public Safety: Lessons from OJP’s Reentry Partnership Initiative,” Justice Policy and Research. 5(2):101-128.

Taxman, F., Young, D. and Byrne, J. M. (2004). “Eyes Wide Open: New Models for Reentry,” in S. Maruno and R. Immarigeon (eds.) After Crime and Punishment. Williams Publishing.

Varvel, S.A., Bridgen, D.T., Tao, Q., Thomas, B.F., Martin, B.R., Lichtman, A.H. (2005). Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects
of marijuana in mice. Journal of Pharmacology and Experimental Therapeutics. 314(1):329-337. Epub 2005 Apr 14.

Varvel, S.A., Anum, E.A., Lichtman, A.H. (2005). Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl). 179(4):863-872. Epub 2004 Dec 24.

Varvel, S.A., Anum, E., Niyuhire, F., Wise, L.E., Lichtman, A.H. (2005). Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology (Berl). 178(2-3):317-327. Epub 2004 Aug 20.

Vatalaro, K. and Hancock, L. (2004). Increasing Credibility of Social Norms Marketing Campaigns Using the “Snowball Survey Intervention.” The Report on Social Norms. Volume 3, No. 7, Garfield, NJ, Paper-Clip Communications.

Velez, M.L., Jansson, L.M., Montoya, I.D., Schweitzer, W., Golden, A., Svikis, D. (2004). Parenting knowledge among substance-abusing women in treatment. Journal of Substance Abuse Treatment. 27(3):215-222.

Ward, K.D., Hammal, F., Vander Weg, M.W., Maziak W., Eissenberg, T., Asfar, T., Rastam, S. (2005). Are waterpipe users interested in quitting? Nicotine and Tobacco Research. 7:149-156.

Weaver, M.F. (2005). In pain or drug seeking? Resident continuity clinic, chronic nonmalignant pain and addiction. Journal of Opioid Management. 1(3):123-124.

Weaver, M.F., Cropsey, K.L., Fox, S.A. (2005). HCV prevalence in methadone maintenance: self-report versus serum test. American Journal of Health Behavior. 29:387-394.

Wesolowska, A., Young, S., Dukat, M. (2004). MD-354 potentiates the antinociceptive effect of clonidine in the mouse tail-flick but not hot-plate assay. European Journal of Pharmacology. 495(2-3):129-36.

Wiley, J.L., LaVecchia, K.L., Karp, N.E., Kulasegram, S., Mahadevan, A., Razdan, R.K., Martin, B.R. (2004). A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Experimental and Clinical Psychopharmacology. 12(3):173-179.

Wiley, J.L., Burston, J.J., Leggett, D.C., Alekseeva, O.O., Razdan, R.K., Mahadevan, A. and Martin, B.R. (2005). CB1 cannabinoid receptor-mediated modulation of food intake in mice. British Journal of Pharmacology. 145:293-300.

Wiley, J.L., Razdan, R.K., Smith, F.L. and Dewey, W.L. (2005). Task specificity of cross tolerance between 9-tetrahydrocannabinol and anandamide analogs in mice. European Journal of Pharmacology. 510:59-68.

York, T.P., Miles, M.F., Kendler, K.S., Jackson-Cook, C., Bowman, M.L., Eaves, L.J. (2005). Epistatic and environmental controls of genome-wide gene expression. Twin Research and Human Genetics. 8(1):5-15.